4.7 Review

Roles of SIRT6 in kidney disease: a novel therapeutic target

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 79, Issue 1, Pages -

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-021-04061-9

Keywords

SIRT6; Chronic kidney disease; Acute kidney disease; Epigenetics; Energy metabolism; Oxidative stress; Cellular homeostasis

Funding

  1. National Natural Science Foundation of China [81770687, 82070713, 81970631, 81670631]

Ask authors/readers for more resources

SIRT6 is a crucial NAD(+) dependent deacetylase primarily located in the nucleus, regulating various physiological activities such as DNA repair, energy metabolism, oxidative stress, inflammation, and fibrosis. In the context of kidney disease, SIRT6 plays a vital role in maintaining cellular homeostasis and delaying disease progression.
SIRT6 is an NAD(+) dependent deacetylase that belongs to the mammalian sirtuin family. SIRT6 is mainly located in the nucleus and regulates chromatin remodeling, genome stability, and gene transcription. SIRT6 extensively participates in various physiological activities such as DNA repair, energy metabolism, oxidative stress, inflammation, and fibrosis. In recent years, the role of epigenetics such as acetylation modification in renal disease has gradually received widespread attention. SIRT6 reduces oxidative stress, inflammation, and renal fibrosis, which is of great importance in maintaining cellular homeostasis and delaying the chronic progression of kidney disease. Here, we review the structure and biological function of SIRT6 and summarize the regulatory mechanisms of SIRT6 in kidney disease. Moreover, the role of SIRT6 as a potential therapeutic target for the progression of kidney disease will be discussed. [GRAPHICS] .

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available